Royal Bank of Canada
FATE icon

Royal Bank of Canada’s Fate Therapeutics FATE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$168K Buy
149,952
+141,377
+1,649% +$158K ﹤0.01% 4942
2025
Q1
$6K Sell
8,575
-5,990
-41% -$4.19K ﹤0.01% 5912
2024
Q4
$24K Buy
14,565
+2,394
+20% +$3.95K ﹤0.01% 5546
2024
Q3
$43K Buy
12,171
+2,339
+24% +$8.26K ﹤0.01% 5311
2024
Q2
$32K Buy
9,832
+7,834
+392% +$25.5K ﹤0.01% 5468
2024
Q1
$15K Sell
1,998
-25,190
-93% -$189K ﹤0.01% 5583
2023
Q4
$102K Buy
27,188
+12,832
+89% +$48.1K ﹤0.01% 5079
2023
Q3
$30K Buy
14,356
+3,863
+37% +$8.07K ﹤0.01% 5530
2023
Q2
$49K Buy
10,493
+3,382
+48% +$15.8K ﹤0.01% 5342
2023
Q1
$41K Sell
7,111
-16,021
-69% -$92.4K ﹤0.01% 5335
2022
Q4
$234K Buy
23,132
+18,557
+406% +$188K ﹤0.01% 4285
2022
Q3
$103K Buy
4,575
+556
+14% +$12.5K ﹤0.01% 4805
2022
Q2
$100K Sell
4,019
-7,157
-64% -$178K ﹤0.01% 4873
2022
Q1
$433K Sell
11,176
-15,772
-59% -$611K ﹤0.01% 3931
2021
Q4
$1.58M Buy
26,948
+16,278
+153% +$953K ﹤0.01% 2919
2021
Q3
$633K Sell
10,670
-139,818
-93% -$8.29M ﹤0.01% 3685
2021
Q2
$13.1M Buy
150,488
+116,185
+339% +$10.1M ﹤0.01% 1474
2021
Q1
$2.83M Buy
34,303
+34,105
+17,225% +$2.81M ﹤0.01% 2385
2020
Q4
$18K Sell
198
-679
-77% -$61.7K ﹤0.01% 5555
2020
Q3
$35K Buy
877
+416
+90% +$16.6K ﹤0.01% 5009
2020
Q2
$16K Buy
461
+180
+64% +$6.25K ﹤0.01% 5199
2020
Q1
$6K Sell
281
-1,882
-87% -$40.2K ﹤0.01% 5474
2019
Q4
$42K Buy
+2,163
New +$42K ﹤0.01% 4933
2019
Q3
Sell
-6
Closed 6041
2019
Q2
$0 Buy
+6
New ﹤0.01% 5897
2018
Q4
Sell
-1,451
Closed -$24K 5892
2018
Q3
$24K Buy
1,451
+1,352
+1,366% +$22.4K ﹤0.01% 4973
2018
Q2
$1K Buy
+99
New +$1K ﹤0.01% 5762
2018
Q1
Sell
-70
Closed 5775
2017
Q4
$0 Sell
70
-3,355
-98% ﹤0.01% 5834
2017
Q3
$14K Buy
+3,425
New +$14K ﹤0.01% 5379
2017
Q2
Sell
-6
Closed 5826
2017
Q1
$0 Buy
+6
New ﹤0.01% 5912
2015
Q4
Sell
-103
Closed -$1K 5891
2015
Q3
$1K Sell
103
-300
-74% -$2.91K ﹤0.01% 5873
2015
Q2
$3K Buy
+403
New +$3K ﹤0.01% 5811